Literature DB >> 28702943

Screening and identification of metabolites of two kinds of main active ingredients and hepatotoxic pyrrolizidine alkaloids in rat after lavage Farfarae Flos extract by UHPLC-Q-TOF-MS mass spectrometry.

Xiaoye Cheng1, Man Liao1, Xinpeng Diao1, Yupeng Sun1, Lantong Zhang1.   

Abstract

Farfarae Flos, the dried flower buds of Tussilago farfara L., is usually used to treat coughs, bronchitic and asthmatic conditions as an important traditional Chinese medicine. Tussilagone and methl butyric acid tussilagin ester are seen as representatives of two kinds of active substances. In addition, the pyrrolizidine alkaloids, mainly senkirkine and senecionine, present in the herb can be hepatoxic. In this study, a rapid and sensitive ultra-high-performance liquid chromatography coupled with hybrid triple quadrupole time-of-flight mass spectrometry method was successfully applied to identify the metabolites of tussilagone, methl butyric acid tussilagin ester, senkirkine and senecionine. A total of 35, 37, 18 and nine metabolites of tussilagone, methl butyric acid tussilagin ester, senkirkine and senecionine in rats were tentatively identified. Hydrolysis, oxidation, reduction and demethylation were the major metabolic reactions for tussilagone and methl butyric acid tussilagin ester. The main biotransformation routes of senkirkine and senecionine were identified as demethylation, N-methylation, oxidation and reduction. This study is the first reported analysis and characterization of the metabolites and the proposed metabolic pathways might provide further understanding of the metabolic fate of the chemical constituents after oral administration of Farfarae Flos extract in vivo.
Copyright © 2017 John Wiley & Sons, Ltd.

Entities:  

Keywords:  Farfarae Flos extract; UHPLC-q-TOF-MS/MS; metabolites; pyrrolizidine alkaloids; sesquiterpenes

Mesh:

Substances:

Year:  2017        PMID: 28702943     DOI: 10.1002/bmc.4047

Source DB:  PubMed          Journal:  Biomed Chromatogr        ISSN: 0269-3879            Impact factor:   1.902


  4 in total

1.  Tussilagone Inhibits Osteoclastogenesis and Periprosthetic Osteolysis by Suppressing the NF-κB and P38 MAPK Signaling Pathways.

Authors:  Xuantao Hu; Ziqing Yin; Xia Chen; Guangyao Jiang; Daishui Yang; Ziqin Cao; Shuai Li; Zicheng Liu; Dan Peng; Pengcheng Dou
Journal:  Front Pharmacol       Date:  2020-04-03       Impact factor: 5.810

Review 2.  A review of the ethnobotanical value, phytochemistry, pharmacology, toxicity and quality control of Tussilago farfara L. (coltsfoot).

Authors:  Shujuan Chen; Lin Dong; Hongfeng Quan; Xirong Zhou; Jiahua Ma; Wenxin Xia; Hao Zhou; Xueyan Fu
Journal:  J Ethnopharmacol       Date:  2020-10-16       Impact factor: 4.360

3.  Development and Validation of Liquid Chromatography-Tandem Mass Spectrometry Method for Pharmacokinetic Evaluation of 7β-(3-Ethyl-cis-crotonoyloxy)-1α-(2-methylbutyryloxy)-3,14-dehydro-Z-notonipetranon in Rats.

Authors:  Nae-Won Kang; Jae-Young Lee; Kwangho Song; Min-Hwan Kim; Soyeon Yoon; Duy-Thuc Nguyen; Sungho Kim; Yeong Shik Kim; Dae-Duk Kim
Journal:  Molecules       Date:  2020-04-13       Impact factor: 4.411

4.  Meta-Analysis on the Chinese Herbal Formula Xiaoer-Feike Granules as a Complementary Therapy for Children With Acute Lower Respiratory Infections.

Authors:  Qiang You; Lan Li; Dan Li; Dan Yang; Lin Chen; Hong-Ping Chen; You-Ping Liu
Journal:  Front Pharmacol       Date:  2020-10-22       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.